Voya Investment Management LLC Cuts Stock Holdings in Enhabit, Inc. $EHAB

Voya Investment Management LLC lowered its stake in shares of Enhabit, Inc. (NYSE:EHAB) by 10.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,351 shares of the company’s stock after selling 1,656 shares during the quarter. Voya Investment Management LLC’s holdings in Enhabit were worth $126,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. GAMMA Investing LLC increased its position in shares of Enhabit by 295.2% during the first quarter. GAMMA Investing LLC now owns 3,533 shares of the company’s stock worth $31,000 after acquiring an additional 2,639 shares during the period. Nuveen Asset Management LLC grew its stake in shares of Enhabit by 95.5% during the fourth quarter. Nuveen Asset Management LLC now owns 265,361 shares of the company’s stock worth $2,072,000 after purchasing an additional 129,610 shares in the last quarter. Nuveen LLC acquired a new position in shares of Enhabit during the first quarter worth $1,773,000. Trexquant Investment LP grew its stake in shares of Enhabit by 30.1% during the first quarter. Trexquant Investment LP now owns 185,603 shares of the company’s stock worth $1,631,000 after purchasing an additional 42,908 shares in the last quarter. Finally, Two Sigma Advisers LP grew its stake in shares of Enhabit by 40.1% during the fourth quarter. Two Sigma Advisers LP now owns 27,600 shares of the company’s stock worth $216,000 after purchasing an additional 7,900 shares in the last quarter.

Analyst Ratings Changes

Separately, UBS Group lowered their target price on shares of Enhabit from $10.00 to $8.50 and set a “neutral” rating for the company in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $8.67.

Insider Transactions at Enhabit

In other news, CFO Ryan Solomon purchased 10,000 shares of the business’s stock in a transaction that occurred on Friday, August 8th. The stock was purchased at an average cost of $7.64 per share, with a total value of $76,400.00. Following the completion of the acquisition, the chief financial officer directly owned 193,468 shares of the company’s stock, valued at approximately $1,478,095.52. This trade represents a 5.45% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 3.40% of the stock is owned by corporate insiders.

Enhabit Price Performance

Shares of EHAB opened at $8.02 on Wednesday. Enhabit, Inc. has a fifty-two week low of $6.47 and a fifty-two week high of $10.90. The company has a market capitalization of $406.53 million, a price-to-earnings ratio of -3.00 and a beta of 1.69. The firm has a 50-day simple moving average of $7.63 and a 200-day simple moving average of $8.41. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.57 and a current ratio of 1.57.

Enhabit (NYSE:EHAB) last announced its earnings results on Wednesday, August 6th. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.03. Enhabit had a negative net margin of 12.84% and a positive return on equity of 2.72%. The business had revenue of $266.10 million during the quarter, compared to the consensus estimate of $263.39 million. On average, equities research analysts anticipate that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.